Monday, October 25, 2021
اُردُو نیوز Newspaper Live-TV(UK) Live-TV(PK)
اُردُو نیوز Newspaper
Live-TV(UK) Live-TV(PK)

Sanofi, BioNTech sign cancer treatment partnership

Sanofi, BioNTech sign cancer treatment partnership
November 3, 2015
PARIS - Sanofi and BioNTech said they signed a collaboration and license agreement to discover and develop up to five cancer immunotherapies, the companies said in a statement on Tuesday. BioNTech will receive $60 million in upfront and near-term milestone payments and could receive over $300 million in development, regulatory and commercial milestones and other payments per product, the companies said. BioNTech would also be eligible for tiered royalties on net sales up to double digits if the treatments are successfully brought to market, the companies added. -Reuters
تازہ ترین خبریں حاصل کرنے کے لیے فوری اطلاع کی اجازت دیں

آپ کسی بھی وقت دائیں طرف نیچے بیل آئیکن پر صرف ایک کلک کے ذریعے آسانی سے سبسکرائب کر سکتے ہیں۔